Human T-Cell Lymphotropic Virus (HTLV 1/2) in Ecuador: Time for Action.

IF 3.8 3区医学 Q2 VIROLOGY

Viruses-Basel Pub Date : 2025-03-20 DOI:10.3390/v17030446

Miguel Angel Garcia-Bereguiain, Solon Alberto Orlando, Melissa Joseth Carvajal Capa, Manuel Gonzalez

引用次数: 0

Abstract

The human T-cell lymphotropic viruses of type 1 and 2 (HTLV 1/2) are retroviruses with estimations of 10 million people infected worldwide. HTLV 1/2 viruses are endemic in South America where Indigenous and Afro American populations are considered of high risk. Although several case reports of HTLV 1/2 associated pathologies and some prevalence studies have been reported in Ecuador, the country lacks a national surveillance and control program, and no screening of blood or organ donors is currently done. We discuss the problems associated to HTLV 1/2 in Ecuador and propose a strategy to improve a surveillance and control program.

查看原文本刊更多论文

厄瓜多尔的人类t细胞嗜淋巴病毒（HTLV 1/2）：是时候采取行动了。

人类t细胞嗜淋巴病毒1型和2型（HTLV 1/2）是逆转录病毒，估计全世界有1000万人感染。HTLV 1/2病毒在南美洲流行，那里的土著和非洲裔美国人被认为是高危人群。尽管厄瓜多尔报告了几例HTLV 1/2相关病理病例和一些流行病学研究，但该国缺乏国家监测和控制规划，目前也没有对献血者或器官捐献者进行筛查。我们讨论了厄瓜多尔HTLV 1/2的相关问题，并提出了改进监测和控制方案的策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Viruses-Basel VIROLOGY-

CiteScore

7.30

自引率

12.80%

发文量

2445

审稿时长

1 months

期刊介绍： Viruses (ISSN 1999-4915) is an open access journal which provides an advanced forum for studies of viruses. It publishes reviews, regular research papers, communications, conference reports and short notes. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. We also encourage the publication of timely reviews and commentaries on topics of interest to the virology community and feature highlights from the virology literature in the ''News and Views'' section. Electronic files or software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.